Classification of liabilities – suppress your creativity!
Here’s another of the issues arising from extracts of enforcement decisions issued in the past by the European Securities and Markets Authority (ESMA); this is from their 25th edition: The issuer is a biotechnology company. In October 2017, the issuer issued debt fully subscribed by company B, for an amount representing around 30% of the…